USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: AuraSense, LLC
Address: 1801 Maple Avenue, Suite 4301
Evanston, IL
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: http://www.aurasense.com
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $300,000.00 2
SBIR Phase II $728,581.00 1
STTR Phase I $100,000.00 1

Award List:

Nano-Flares for the Intracellular Detection of miRNA in Living Cells

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: David A. Giljohann
Award Amount: $200,000.00
Abstract:
DESCRIPTION (provided by applicant): Under the auspices of this small business innovation research (SBIR) grant, AuraSense LLC will develop a novel nanotechnology, Nano-flares , for the detection of low abundance microRNA (miR) species in living cells in real-time. MicroRNAs are short (~22… More

Modified Nanoparticles for Lipophilic Toxin Sequestration

Award Year / Program / Phase: 2011 / STTR / Phase I
Agency / Branch: DOD / USAF
Research Institution: Northwestern University
Principal Investigator: Weston Daniel, Research Scientist – (847) 467-2874
Award Amount: $100,000.00
RI Contact: C. S. Thaxton
Abstract:
ABSTRACT: Mycotoxins are a class of weaponizable toxic secondary metabolites of molds and fungi. No treatments exist for exposure to these lipophilic poisons. AuraSense proposes to use lipid and protein modified gold nanoparticles to develop constructs for the sequestration of toxic lipophilic… More

Cell Regulation with Polyvalent Nanoparticles

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: DOD
Principal Investigator: David Giljohann, Research Scientist – (847) 467-2874
Award Amount: $100,000.00
Abstract:
ABSTRACT: Polyvalent nanoparticle constructs have unique properties that make them ideal for gene regulation applications, while overcoming many of the challenges which have prevented oligonucleotides from being developed into viable therapies. Specifically, AuraSense is developing constructs… More

Cell Regulation with Polyvalent Nanoparticles

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: DOD
Principal Investigator: David Giljohann, Chief Scientific Officer – (847) 467-2887
Award Amount: $728,581.00
Abstract:
ABSTRACT: AuraSense is developing and commercializing NanoFlare technology as an enabling tool for detecting RNA levels in cells. Current methods for sensing of viral exposure require great amounts of virus particles to be present in blood, or extensive processing of blood to isolate virus-specific… More